tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
Advertisement

Bright Minds Biosciences (DRUG) Technical Analysis

Compare
244 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bright Minds Biosciences’s (DRUG) Moving Averages Convergence Divergence (MACD) indicator is 3.38, suggesting Bright Minds Biosciences is a Buy.
Bright Minds Biosciences’s (DRUG) 20-Day exponential moving average is 52.53, while Bright Minds Biosciences’s (DRUG) share price is $61.41, making it a Buy.
Bright Minds Biosciences’s (DRUG) 50-Day exponential moving average is 46.37, while Bright Minds Biosciences’s (DRUG) share price is $61.41, making it a Buy.

Bright Minds Biosciences (DRUG) Pivot Points

Oct 10, 2025, 11:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
45.59
47.72
51.46
53.58
57.32
59.45
63.19
Fibonacci
47.72
49.96
51.34
53.58
55.82
57.21
59.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bright Minds Biosciences (DRUG) Moving Averages

Oct 10, 2025, 11:51 AM
Period
Simple
Exponential
MA5
54.44Buy
56.29Buy
MA10
55.70Buy
54.96Buy
MA20
52.62Buy
52.53Buy
MA50
45.53Buy
46.37Buy
MA100
36.78Buy
41.20Buy
MA200
35.97Buy
39.19Buy
Bright Minds Biosciences’s (DRUG) 10-Day exponential moving average is 54.96, while Bright Minds Biosciences’s (DRUG) share price is $61.41, making it a Buy.
Bright Minds Biosciences’s (DRUG) 100-Day exponential moving average is 41.20, while Bright Minds Biosciences’s (DRUG) share price is $61.41, making it a Buy.
Bright Minds Biosciences’s (DRUG) stock price is $61.41 and Bright Minds Biosciences’s (DRUG) 50-day simple moving average is 45.53, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $61.41 and Bright Minds Biosciences’s (DRUG) 100-day simple moving average is 36.78, creating a Buy signal.
Bright Minds Biosciences’s (DRUG) stock price is $61.41 and Bright Minds Biosciences’s (DRUG) 200-day simple moving average is 35.97, creating a Buy signal.

Bright Minds Biosciences (DRUG) Technical Indicators

Oct 10, 2025, 11:51 AM
Name
Value
Implied Action
RSI (14)
66.47
Neutral
STOCH (9,6)
53.88
Neutral
STOCHRSI (14)
61.43
Neutral
MACD (12,26)
3.38
Buy
ADX (14)
39.61
Neutral
Williams %R
-2.42
Sell
CCI (14)
137.81
Sell
ATR (14)
4.24
-
Ultimate Oscillator
51.98
Neutral
ROC
15.26
Buy
Bright Minds Biosciences’s (DRUG) Relative Strength Index (RSI) is 66.47, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Trend Strength Indicator (ADX) is 39.61, creating a Neutral signal.
Bright Minds Biosciences’s (DRUG) Commodity Channel Index (CCI) is 137.81, creating a Sell signal.
Bright Minds Biosciences’s (DRUG) Price Rate of Change (ROC) is 15.26, creating a Buy signal.

FAQ

Is DRUG a Buy, Hold, or Sell?
Based on DRUG’s technical indicators, DRUG is a Strong Buy.
    What is DRUG’s RSI (14)?
    DRUG’s RSI (14) is 66.47, which suggests DRUG is a Neutral.
      What is DRUG’s MACD?
      DRUG’s MACD is 3.38, which suggests DRUG is a Buy.
        What is DRUG’s 5-day moving average?
        DRUG’s 5-day moving average is 54.44, which suggests DRUG is a Buy.
          What is DRUG’s 20-day moving average?
          DRUG 20-day moving average is 52.62, which suggests DRUG is a Buy.
            What is DRUG’s 50-day moving average?
            DRUG’s 50-day moving average is 45.53, which suggests DRUG is a Buy.
              What is DRUG’s 200-day moving average?
              DRUG’s 200-day moving average is 35.97, which suggests DRUG is a Buy.
                What is DRUG’s Williams % R (14)?
                DRUG’s Williams % R (14) is -2.42, which suggests DRUG is a Sell.
                  What is DRUG’s CCI (14)?
                  DRUG’s CCI (14) is 137.81, which suggests DRUG is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis